• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY ICL (IMPLANTABLE COLLAMER LENS); INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY ICL (IMPLANTABLE COLLAMER LENS); INTRAOCULAR LENS Back to Search Results
Model Number ICM125V4
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Cataract, Induced (1767); Reaction (2414)
Event Date 07/05/2014
Event Type  Injury  
Event Description
The reporter indicated the surgeon implanted a 12.5mm icm125v4 implantable collamer lens in the patient's right eye (od) on (b)(6) 2014.The lens was explanted on (b)(6) 2014 due to lens opacity, which was noted on (b)(6) 2014.The surgeon suspects toxic reaction from visco or lens.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
Method: work order search, medical review.Results: a lens work order search was performed and no similar complaints were found within the work order.Visual inspection of the returned product found no visible damage to the lens.The lens was returned dry.The lens was rehydrated in bss for re-measurement.The lens length was measured and the result of the measurement was compared against the original value and the lens was found to be in specification.Medical review - toxic reactions may be due (but not limited) to: contaminated or inappropriate intraocular medication/irrigation fluids, instruments with residual toxins from sterilization, iol with residual toxic particles, etc.It is unlikely that the icl was the cause of this adverse event.Every icl undergoes a steam sterilization process.Before releasing the lens, quality department verifies the following for each icl lot: sterilization cycle parameters (time, temperature and pressure) must be met.Biological indicators used for every sterilization batch must be in accordance with specifications to demonstrate sterility.Lal testing must be in accordance with specifications to ensure that the product is free from any endotoxin.A review of the device history record was performed and nothing was found in the manufacturing, sterilization and packaging processes of this lens that was the root cause of the complaint.Conclusions: based on the complaint history, work order search, medical review, device history record review and the evaluation of the returned product, a specific root cause of the event could not be determined.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ICL (IMPLANTABLE COLLAMER LENS)
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
haupstrasse 104
nidau, CH-25 60
SZ  CH-2560
Manufacturer (Section G)
STAAR SURGICAL COMPANY
haupstrasse 104
nidau, CH-2 560
SZ   CH-2560
Manufacturer Contact
althea watson
1911 walker avenue
monrovia, CA 91016
6263037902
MDR Report Key3985424
MDR Text Key4884373
Report Number2023826-2014-00608
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P030016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/15/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date04/30/2017
Device Model NumberICM125V4
Other Device ID NumberDIOPTER -16.5
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/29/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/09/2014
Initial Date FDA Received08/06/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/07/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/09/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTRIDGE MODEL AND LOT NUMBER UNK; INJECTOR MODEL AND LOT NUMBER UNK
Patient Outcome(s) Required Intervention;
-
-